Minnesota Attorney General Targets Sanofi, Lilly & Novo Nordisk in Latest Insulin Pricing Suit

Oct 19, 2018 | Insulin, Lawsuit, Minnesota Attorney General, Novo Nordisk, Pricing

Minnesota Attorney General Lori Swanson has filed a major legal action against Sanofi, Novo Nordisk and Lilly for alleged deceptive price hikes. Filed in New Jersey, the AG argues that commercial pharma has shot up prices so high that they are not “accurate approximation of the true cost of insulin” and are misleading. The allegation is that the pharmas are in a race to raise list prices while increasing rebates in move to secure favorable formulary placement.


Pin It on Pinterest